CUSIP: 627335201
What is CUSIP 627335201?
CUSIP 627335201 identifies 627335201 - MUSCLE PHARM CORP - COMM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 627335201:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q2 | 0 | $0 | -$20 | 0 | |
| 2024 Q1 | 17,320 | $20 | +$20 | $0.00 | 1 |
| 2023 Q4 | 0 | $0 | -$8 | 0 | |
| 2023 Q3 | 17,320 | $8 | $0.00 | 1 | |
| 2023 Q2 | 17,320 | $51 | $0.00 | 1 | |
| 2023 Q1 | 17,320 | $36 | -$1,492 | $0.00 | 1 |
| 2022 Q4 | 2,148,264 | $1,504 | $0.00 | 2 | |
| 2022 Q3 | 2,148,264 | $397,000 | $0.18 | 2 | |
| 2022 Q2 | 2,148,264 | $366,000 | $0.17 | 2 | |
| 2022 Q1 | 2,148,264 | $644,000 | -$1,459,000 | $0.29 | 2 |
| 2021 Q4 | 5,796,619 | $2,318,000 | +$1,459,000 | $0.40 | 3 |
| 2021 Q3 | 2,148,264 | $2,019,000 | -$7,224,000 | $0.93 | 2 |
| 2021 Q2 | 5,796,619 | $11,477,000 | +$37,756 | $1.98 | 3 |
| 2021 Q1 | 5,777,549 | $5,777,000 | $1.00 | 3 | |
| 2020 Q4 | 5,777,549 | $1,179,000 | +$20,402 | $0.20 | 3 |
| 2020 Q3 | 5,677,580 | $284,000 | $0.05 | 3 | |
| 2020 Q2 | 5,677,580 | $852,000 | +$11,348 | $0.15 | 3 |
| 2020 Q1 | 5,601,980 | $1,294,000 | +$25,686 | $0.23 | 3 |
| 2019 Q4 | 5,490,808 | $1,318,000 | +$150,424 | $0.24 | 2 |
| 2019 Q3 | 4,863,982 | $2,188,000 | +$11,744 | $0.45 | 2 |
| 2019 Q2 | 4,838,982 | $1,694,000 | +$4,444 | $0.35 | 3 |
| 2019 Q1 | 4,826,276 | $3,039,000 | +$73,844 | $0.63 | 3 |
| 2018 Q4 | 4,708,982 | $2,638,000 | +$1,704,404 | $0.56 | 3 |
| 2018 Q3 | 1,666,305 | $1,849,000 | +$399,492 | $1.10 | 2 |
| 2018 Q2 | 1,306,305 | $876,000 | -$26,815 | $0.69 | 2 |
| 2018 Q1 | 1,346,305 | $1,037,000 | $0.78 | 2 | |
| 2017 Q4 | 1,346,305 | $876,000 | -$195,090 | $0.68 | 2 |
| 2017 Q3 | 1,646,305 | $2,140,000 | +$208,696 | $1.30 | 2 |
| 2017 Q2 | 1,485,755 | $2,892,000 | +$186,730 | $1.97 | 2 |
| 2017 Q1 | 1,389,805 | $2,939,000 | +$379,256 | $2.11 | 2 |
| 2016 Q4 | 1,210,470 | $2,119,000 | +$87,507 | $1.78 | 2 |
| 2016 Q3 | 1,160,470 | $2,344,000 | +$290,573 | $2.01 | 2 |
| 2016 Q2 | 1,016,625 | $2,745,000 | -$1,000 | $2.70 | 2 |
| 2016 Q1 | 1,017,116 | $3,061,000 | +$155,503 | $3.00 | 3 |
| 2015 Q4 | 967,430 | $2,206,000 | +$493,681 | $2.30 | 2 |
| 2015 Q3 | 750,160 | $2,250,000 | -$7,456 | $3.00 | 2 |
| 2015 Q2 | 752,652 | $4,584,000 | -$2,340,595 | $6.09 | 2 |
| 2015 Q1 | 1,148,724 | $5,169,000 | -$1,615,041 | $4.50 | 3 |
| 2014 Q4 | 1,354,663 | $11,514,000 | +$1,608,143 | $8.50 | 5 |
| 2014 Q3 | 1,165,450 | $15,784,000 | +$543,385 | $13.39 | 2 |
| 2014 Q2 | 1,125,450 | $13,618,000 | -$208,733 | $12.10 | 2 |
| 2014 Q1 | 1,142,700 | $7,313,000 | -$107,487 | $6.40 | 2 |